Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond A Dionne

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Compendium of Continuing Education in Dentistry (Jamesburg, N.J. : 1995)|September 9, 2016
Proposed Guideline Revisions for Dental Sedation and General Anesthesia: Why Target the Safest Level of Sedation?Raymond A Dionne
Journal of the American Dental Association (1939)|February 27, 2017
Raise the bar for safe sedation, not barriers for access to careRaymond A Dionne
Arthritis Research & Therapy|November 13, 2004
What can chronic arthritis pain teach about developing new analgesic drugs?James Witter, Raymond A Dionne
Molecular Pain|March 9, 2007
Lack of influence of GTP cyclohydrolase gene (GCH1) variations on pain sensitivity in humansHyungsuk Kim, Raymond A Dionne
Current Molecular Pharmacology|September 26, 2009
Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibitionMay Hamza, Raymond A Dionne
Drug Discovery Today. Therapeutic Strategies|October 1, 2011
Individualized pain medicineHyungsuk Kim, Raymond A Dionne
Pain|April 5, 2007
Comment on Diatchenko et al. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain 2006;125:216-24Hyungsuk Kim, Raymond A Dionne
The Clinical Journal of Pain|June 7, 2003
NIH-FDA Analgesic Drug Development Workshop: translating scientific advances into improved pain reliefRaymond A Dionne, James Witter
Drug Discovery Today. Therapeutic Strategies|June 30, 2011
2020 Foresight: Envisioning Therapeutic Innovations for PainMay Hamza, Raymond A Dionne
Dental Clinics of North America|November 20, 2002
The COX-2 inhibitors: new analgesic and anti-inflammatory drugsAsma A Khan, Raymond A Dionne
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Compendium of Continuing Education in Dentistry (Jamesburg, N.J. : 1995)|September 9, 2016
Proposed Guideline Revisions for Dental Sedation and General Anesthesia: Why Target the Safest Level of Sedation?Raymond A Dionne
Journal of the American Dental Association (1939)|February 27, 2017
Raise the bar for safe sedation, not barriers for access to careRaymond A Dionne
Arthritis Research & Therapy|November 13, 2004
What can chronic arthritis pain teach about developing new analgesic drugs?James Witter, Raymond A Dionne
Molecular Pain|March 9, 2007
Lack of influence of GTP cyclohydrolase gene (GCH1) variations on pain sensitivity in humansHyungsuk Kim, Raymond A Dionne
Current Molecular Pharmacology|September 26, 2009
Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibitionMay Hamza, Raymond A Dionne
Drug Discovery Today. Therapeutic Strategies|October 1, 2011
Individualized pain medicineHyungsuk Kim, Raymond A Dionne
Pain|April 5, 2007
Comment on Diatchenko et al. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain 2006;125:216-24Hyungsuk Kim, Raymond A Dionne
The Clinical Journal of Pain|June 7, 2003
NIH-FDA Analgesic Drug Development Workshop: translating scientific advances into improved pain reliefRaymond A Dionne, James Witter
Drug Discovery Today. Therapeutic Strategies|June 30, 2011
2020 Foresight: Envisioning Therapeutic Innovations for PainMay Hamza, Raymond A Dionne
Dental Clinics of North America|November 20, 2002
The COX-2 inhibitors: new analgesic and anti-inflammatory drugsAsma A Khan, Raymond A Dionne
Pageof 6